CONTRI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.026
NA - Nord America 1.004
EU - Europa 610
SA - Sud America 190
AF - Africa 70
OC - Oceania 23
Totale 2.923
Nazione #
US - Stati Uniti d'America 938
SG - Singapore 319
IT - Italia 299
CN - Cina 175
BR - Brasile 126
VN - Vietnam 119
HK - Hong Kong 85
BD - Bangladesh 81
FR - Francia 67
GB - Regno Unito 55
DE - Germania 50
JP - Giappone 49
CA - Canada 43
IN - India 38
EG - Egitto 34
CO - Colombia 29
CH - Svizzera 21
ID - Indonesia 20
NL - Olanda 20
RU - Federazione Russa 18
AR - Argentina 17
ZA - Sudafrica 17
IR - Iran 15
MX - Messico 14
TR - Turchia 14
NZ - Nuova Zelanda 13
IL - Israele 12
IQ - Iraq 11
PK - Pakistan 11
AU - Australia 10
ES - Italia 10
KR - Corea 10
KZ - Kazakistan 9
BE - Belgio 8
IE - Irlanda 8
PH - Filippine 8
PL - Polonia 8
FI - Finlandia 7
MY - Malesia 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
EC - Ecuador 6
AT - Austria 5
KE - Kenya 5
MA - Marocco 5
SE - Svezia 5
RS - Serbia 4
UA - Ucraina 4
GR - Grecia 3
JO - Giordania 3
KW - Kuwait 3
NG - Nigeria 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
OM - Oman 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 2.923
Città #
Singapore 202
Ashburn 187
San Jose 116
Hong Kong 81
Council Bluffs 67
Beijing 49
New York 47
Los Angeles 43
Santa Clara 40
Tokyo 36
Ho Chi Minh City 33
Cairo 29
Hanoi 29
Meridian 28
Ferrara 26
Albosaggia 24
Milan 23
Naples 21
Munich 20
Jakarta 18
Lauterbourg 18
Bogotá 17
São Paulo 16
Montreal 15
Shanghai 15
Denver 14
Zurich 14
Toronto 13
Buffalo 12
Chennai 12
Dallas 12
Rome 12
Chandler 11
Hefei 11
Da Nang 10
Bologna 9
Manchester 9
Orem 9
Tannowa 9
Tucson 9
Almaty 8
Brooklyn 8
Galway 8
Medellín 8
Ankara 7
Bari 7
Chicago 7
Johannesburg 7
Malonne 7
Warsaw 7
Campinas 6
Haiphong 6
Livorno 6
Louisville 6
Phoenix 6
Tashkent 6
Venice 6
Atlanta 5
Azusa 5
Baghdad 5
Boston 5
Chattanooga 5
Christchurch 5
Curitiba 5
Dresden 5
Dunedin 5
Florence 5
Frankfurt am Main 5
Geneva 5
Madrid 5
Parma 5
Rio de Janeiro 5
Tel Aviv 5
Auburn 4
Charlotte 4
Falkenstein 4
Kuala Lumpur 4
London 4
Melbourne 4
Moscow 4
Nairobi 4
Nashville 4
Pisa 4
Poplar 4
Redondo Beach 4
Salt Lake City 4
San Diego 4
Taranto 4
The Dalles 4
Vienna 4
Athens 3
Auckland 3
Belo Horizonte 3
Blumenau 3
Boardman 3
Brisbane 3
Bristol 3
Can Tho 3
Cuauhtémoc 3
Fairfield 3
Totale 1.660
Nome #
Pharmacological characterization of new modulators of the endocannabinoid system: from single target to multi-target compounds 772
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 160
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 159
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 158
Adenosine and inflammation: Here, there and everywhere 154
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 144
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 135
Pharmacology of Adenosine Receptors: Recent Advancements 133
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 128
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 122
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 119
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 117
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 115
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 114
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 109
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 97
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study. 96
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 63
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy 51
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells 39
Totale 2.985
Categoria #
all - tutte 10.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 0 0 0 0 7 0 0 8 3
2022/202331 3 5 0 3 2 3 6 2 3 0 3 1
2023/2024203 5 3 4 1 20 0 3 3 4 58 43 59
2024/2025752 42 52 53 39 58 74 49 53 111 68 82 71
2025/20261.938 180 72 153 178 254 127 179 136 159 240 168 92
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 2.985